BCL2 interacting protein 3 pseudogene 25 (BNIP3P25)

**BCL2 interacting protein 3 pseudogene 25** (BNIP3P25) is classified as a pseudogene, based on current genomic databases and authoritative gene resources[1]. Pseudogenes are typically genomic DNA sequences similar to normal genes but generally non-functional and not translated into proteins. BNIP3P25 has no established protein product, known biological function, molecular activity, or disease association. It does not serve as a direct therapeutic target, receptor, enzyme, transporter, transcription factor, or any classical target class, and there is no information linking it to known drugs, biomarker roles, or safety concerns. The designation "pseudogene" indicates that there may be some sequence similarity to the functional gene **BNIP3** (BCL2 interacting protein 3), but BNIP3P25 itself is not an active gene[1]. **Note**: - If you are seeking functional or therapeutic information, this entry likely reflects either a misidentification or a non-target, as pseudogenes are generally not actionable in drug discovery. For functional and disease-associated information, refer instead to **BNIP3** or related BCL2 family proteins[1].

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 25BNIP3P25